Halozyme Therapeutics | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amarin USD 531.38M 20.5M 2024-09
Amgen USD 6.21B 330M 2025-03
Baxter International USD 6.96B 908M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
DBV Technologies USD 27.4M 26.63M 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Indivior -285000000 63M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
MannKind USD -78816000 131.11M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03



Halozyme Therapeutics Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.